Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
NLSP logo

NLSP

NSC
NLS Pharmaceutics Ltd.
ManufacturingPharmaceutical Preparation Manufacturing
Watchlists:
Last updated: Tuesday 15th July 2025
2.18
+0.03 (1.39%)
Prev Close:2.13
Open:2.12
Bid:2.11
Ask:2.17
52 Week Range
1.30
15.60
Volume:267,224
Mkt Cap:8 M
Price Target
$2.51
+15.1%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

NLSP - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Invalid date
Accrued Preferred Stock Dividends-2 M
General And Administrative Expense3 M6 M7 M6 M2 M
Gross Profit Margin (profit Margin After CGS)16 M2 M
Interest Expense Non Operating150017.0145153.0100866.068134.0233700.0
Interest Expense Operating-2743.0-732.0-24100.0
Misc Other Special Charges3 M219812.010045.0-17323.0-328365.0
Net Income (loss)-2 M-12 M-16 M-12 M-3 M
Net Income Common Stockholders95370.0-12 M-16 M-12 M-3 M
Net Income Continuous Operations-2 M-12 M-16 M-12 M-3 M
Net Income From Other Gains Losses-922495.0
Net Non Operating Interest Income Expense-150017.0-145153.0-100866.0-68134.0-233700.0
Non Recurring Operation Expense132358.0
Normalized Income-1 M-9 M
Operating Income-4 M-12 M-15 M-12 M-2 M
Operating Income Before Depreciation (EBITDA)-2 M-12 M-15 M-12 M-3 M
Operating Expense4 M12 M-15 M12 M2 M
Other Gand A3 M6 M7 M6 M2 M
Other Impairment Of Capital Assets683.0
Other Operating Expenses-2 M
Otherunder Preferred Stock Dividend-2 M
Preferred Stock Dividends-2 M
Rent And Landing Fees7 M
Research Expense9 M6 M99580.0
Restructring And Mn A Income743838.0
Salaries And Wages-12500.0
Selling And Marketing Expense-285859.0
Total Income Available For Interest Expense (EBIT)-2 M-12 M-15 M-12 M-3 M
Total Revenues16 M2 M
Total Expenses4 M12 M-15 M12 M2 M
Total Revenue16 M2 M
Write Down683.0
Amord-48088.0
Avgshs2 M954401.020 M12 M7 M
Avgshsdt2 M954401.020 M12 M7 M
Basiceps-2.63-12.75-0.84-1.0
Basicepscont-2.63-12.75-1.0
Dileps-2.63-12.75-0.84-1.0
Dilepscont-2.63-12.75
Netincdisc-2 M-12 M-16 M-12 M-3 M
Othincexp-3 M-219812.0-110993.017323.0329048.0
Othspecchg132358.0
Pretaxinc-2 M-12 M-15 M-12 M-3 M
Resdev422051.06 M9 M6 M99580.0
Restruct743838.0
Sga3 M6 M7 M6 M2 M
Shsout3 M4 M32 M16 M7 M
Specincchg-743838.0-132358.0-683.0
Taxprov-1 M-1 M-384301.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader